drugset / Trial / NCT01059123
Short Course of Amoxicillin for Erysipelas
Phase 4
Terminated
10 enrolled
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France · collabSociété de Dermatologie Française · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The propose of this study is to determine whether a 6-day duration of oral amoxicillin treatment of erysipelas is non-inferior to a 14-day standard duration intravenous then oral amoxicillin regimen. This trial will be open but evaluation will be perform by a blind evaluator.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-07
- Completion
- 2011-07
Outcome
Outcome not reported
Stopped: “Insufficient number of inclusion”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 50 mg/kg | Oral |